Argenx reports full year 2022 financial results and provides fourth quarter business update

$ 1 7 3 million in fourth quarter and $ 401 million in full year 2022 vyvgart® (efgartigimod alfa- fcab ) global net product sales
ARGX Ratings Summary
ARGX Quant Ranking